ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

140 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 62,550,973 shares of 98,567,360 outstanding shares and own 63.46% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (11,077,927 shares), RA CAPITAL MANAGEMENT, L.P. (10,860,977 shares), ORBIMED ADVISORS LLC (9,240,887 shares), BlackRock Inc. (4,084,339 shares), SR One Capital Management, LP (4,012,903 shares), VANGUARD GROUP INC (3,250,927 shares), FRANKLIN RESOURCES INC (2,950,963 shares), K2 PRINCIPAL FUND, L.P. (2,461,672 shares), Nextech Invest Ltd. (1,910,029 shares), and STATE STREET CORP (1,856,221 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.